Recursion Logo (PRNewsfoto/Recursion)

Recursion Logo (PRNewsfoto/Recursion)

Support Local Journalism

SALT LAKE CITY, Aug. 2, 2022 /PRNewswire/ -- Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its participation in the following investor conference:


Please be aware that Cache Valley Publishing does not endorse, and is not responsible for alleged employment offers in the comments.

Recommended for you